GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of is it normal to get fatigue at week 90 — 50 comments in the full submission. View in context.
4.5k
c/retatrutide·submitted 9 months ago by u/injection_site_iris

is it normal to get fatigue at week 90

Discussionbranch of 7 comments

Quick one. Canada here. glucagon works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 20 weeks and cost roughly what I expected. The admin was worse than the…

Read the full submission and all 50 comments →

This branch

7 comments, started 9 months ago
u/ledger_modMOD353 points·9 months ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
u/kavya_kravchenko99 points·9 months ago

This is an urgent-care question wearing a forum question's clothes.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/nikhil_lindqvist79 points·9 months ago

phase 2 numbers are not maintenance numbers, cite the trial

replysharereportpermalink
u/janek_ferrari51 points·9 months ago

Not to be pedantic but TRIUMPH and retatrutide are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/tired_ledger_notes39 points·9 months ago

the glucagon component changes the side effect profile, not just the efficacy

replysharereportpermalink
u/niels_lindqvist21 points·9 months ago

the dosing is steep, the injection-site soreness reports are real, and nobody knows the human safety yet

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.